Get the royalty agreement signed and bankruptcy better be a

New Post Public Reply Private Reply Replies (1) Message Board
plutonium jrockford #7967
367
Get the royalty agreement signed and bankruptcy better be a non-issue. This companies survival should not be predicated on a j&j settlement.

How about saying something like "I would like to see a royalty agreement signed." or "the company's survival should be predicated on the company's business prospects and not a litigation with J&J." Definitive statements like those above make you, a shareholder (I think), sound like you're running the company. The Starbucks worker who sells me my morning coffee does not run the coffee company and his opinions are his opinions thats all.


If it is, we have been seriously misled.

File your complaint with the SEC or FBI or use one of the many securities class action firms that Always contacted who have already passed on Always case -- or laughed at him.


Again, I don’t need message board posters informing about the company. Need to hear it from DECN. Makes you think there really wasn’t four prospective partners if the ongoing business is about a j&j - platinum linkage.

Good, call DECN and ask. I am sure the company will discuss sensitive business information, negotiations, and contracts with a NOBO. That's what companies do isn't it? And if they don't, it would be a novel new approach. It would end the need for quarterly reporting.


If you are correct about shareholders wanting dividends and the number of shareholders wanting a dividend then there is no trust in KB and the company. That speaks volumes to the companies inability to evolve and lack of faith that the company can evolve.

Of all of these angry comments this is the best one. It infers that DECN's shareholders give a skat about anything other than share price. You seem to be a smart guy. Where did the idea that NOBOs cared where the company succeeds or evolves at all come from. This, as I have said over and over, is about share price and share price alone. Anything else said or posted is an afterthought. All IMO.


$25M is not fine in my book and is an insult to the company and patient shareholders.

You are entitled to your opinions as is everyone. So call KB and tell him. You know what he will tell you "we don't have a settlement offer yet" and "NOBOS will not be allowed into the room with the mediator and J&J to put their two cents in." If you think $25 million for patent infringement is a bad idea, then tell KB, or better yet write to him. Or best yet, remove KB, replace him with yourself, and decide as the new CEO what is fair. And I will sit back and watch it all happen and thank you for your time.


A little statement here by this message board poster and shareholder. I have been in this stock since 2002. I invested into KB's private Medicius company in 1999 which was acquired by what is now DECN in 2002. So, I have been around awhile. 20 years. In that time through good fortunes and bad I have seen absolutely nothing change. In good times when the stock increased, and it has on several longer occasions, NOBOS accepted the increase with their entitled little hearts and sold. Most never looked back. Some are still with us -- sadly. But for the most part NOBOS and non-shareholder message board hitmen have acted kept up the hit parade. Management is corrupt. Management is lying. Management is stealing. It is all corrupt.

Today's posts are no different. And why Mr. Berman puts up with this is the big mystery -- at least to me.

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing the Game: NEWTON GOLF's Gravity Putter Launch

Updated Category News Views 260

Revolutionizing the Game with Gravity Putters Gravity, the putter division of NEWTON GOLF, has just launched an exciting new lineup of five premium putters as part of their latest series. This release marks an important milestone following the company’s rebranding efforts, highlighting their commitment to innovation in the golfing world. Overview of the New Gravity...

Continue Reading
Hikvision's 2024 Financial Success and Future Innovations

Updated Category News Views 644

Hikvision's Impressive Financial Results for 2024 Hikvision has proudly announced its financial results for the latest fiscal year, showcasing remarkable achievements. In 2024, the company generated total revenue of RMB 92.496 billion, reflecting a steady year-over-year growth rate of 3.53%. The company's first-quarter revenue for 2025 also demonstrated strength,...

Continue Reading
Verkada Enhances Security Solutions with SimonsVoss Partnership

Updated Category News Views 204

Verkada Enhances Security Solutions with SimonsVoss Partnership Verkada, a leader in cloud-based physical security, has unveiled a new integration with SimonsVoss wireless locks during the VerkadaOne London conference in front of over 400 IT and security professionals. This partnership marks a significant step forward for Verkada as they aim to improve access control...

Continue Reading
NVIDIA’s European AI Initiative: Innovation and Sovereignty

Updated Category News Views 514

NVIDIA’s European AI Initiative: Innovation and Sovereignty NVIDIA is embarking on a transformative journey across Europe, collaborating with various nations and technology leaders to establish groundbreaking AI infrastructure. This initiative focuses on solidifying digital sovereignty, boosting economic growth, and positioning Europe at the forefront of the global AI...

Continue Reading
Zevra Therapeutics Expands Workforce with New Inducement Grants

Updated Category News Views 72

Zevra Therapeutics Expands Workforce with New Inducement Grants CELEBRATION, Fla. — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) is making strides to enhance its workforce by granting options to purchase a total of 53,000 shares of the company’s common stock. This initiative is part of the 2023 Employment Inducement Award Plan aimed at attracting new talent, particularly...

Continue Reading